SEC 13F Intelligence

Renaissance Technologies LLC / NBIX

Renaissance Technologies LLC’s Neurocrine Biosciences Inc Position

Does Renaissance Technologies LLC own Neurocrine Biosciences Inc (NBIX)? Yes — 2.42M shares worth $319M (+0.50% of its 13F portfolio) as of Q1 2026, up from 2.24M shares the prior filed quarter.

Position Value
$319M
Q1 2026
Shares
2.42M
% of Portfolio
+0.50%
Quarters Held
26
currently held

Position History NBIX

Reported value by quarter
Q4 ’19: $79MQ4 ’19Q1 ’20: $62MQ2 ’20: $181MQ3 ’20: $207MQ4 ’20: $173MQ4 ’20Q1 ’21: $136MQ2 ’21: $121MQ3 ’21: $130MQ4 ’21: $121MQ4 ’21Q1 ’22: $120MQ2 ’22: $141MQ3 ’22: $153MQ4 ’22: $192,736Q4 ’22Q1 ’23: $197,082Q2 ’23: $154,973Q3 ’23: $178,893Q4 ’23: $262,011Q4 ’23Q1 ’24: $310,547Q2 ’24: $340MQ3 ’24: $297MQ4 ’24: $340MQ4 ’24Q1 ’25: $277MQ2 ’25: $297MQ3 ’25: $339MQ4 ’25: $318MQ4 ’25Q1 ’26: $319Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.42M$319M+0.50%
Q4 20252.24M$318M+0.49%
Q3 20252.42M$339M+0.45%
Q2 20252.37M$297M+0.40%
Q1 20252.50M$277M+0.42%
Q4 20242.49M$340M+0.50%
Q3 20242.57M$297M+0.45%
Q2 20242.47M$340M+0.58%
Q1 20242.25M$310,547+0.49%
Q4 20231.99M$262,011+0.41%
Q3 20231.59M$178,893+0.31%
Q2 20231.64M$154,973+0.22%
Q1 20231.95M$197,082+0.26%
Q4 20221.61M$192,736+0.26%
Q3 20221.44M$153M+0.22%
Q2 20221.45M$141M+0.17%
Q1 20221.28M$120M+0.14%
Q4 20211.42M$121M+0.15%
Q3 20211.36M$130M+0.17%
Q2 20211.24M$121M+0.15%
Q1 20211.40M$136M+0.17%
Q4 20201.81M$173M+0.19%
Q3 20202.15M$207M+0.21%
Q2 20201.48M$181M+0.16%
Q1 2020719.4K$62M+0.06%
Q4 2019739.2K$79M+0.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Renaissance Technologies LLC’s full portfolio or all institutional holders of NBIX.